According to Twitter reports, an investigator at the Lugano conference reportedly said that an Adcetris+Rituxan study might be stopped due to pancreatitis. It apparently was an offhand comment, without any backing or substantiation. And it apparently was not in the context of SGEN's major Adcetris trials. Informed commentators on Twitter are casting doubt on the significance of the comment and have asked Seattle Genetcs to comment.
Thanks for passing it on. Can't believe it to be true and Clay not mentioning it. So far he has been transparent and forthcoming with details and keeping it hidden would be a trust buster from which no good can come out. Hopefully he addresses it ASAP because lingering rumors can do significant and lasting damage to the franchise.